Authors
Huabin He, Jianhai Chen
Published in
Endocrinology, diabetes & metabolism. Volume 9. Issue 6.
Abstract
Hypertension is a major global public health issue, and the continuous search for new biomarkers to optimize risk stratification is crucial. This study aims to investigate the relationship between a novel metabolic disorder diagnostic tool-cholesterol, high-density lipoprotein, and glucose (CHG) index-and the incidence of hypertension in populations with different sexes and glycemic statuses.
This study utilized 9 years of follow-up data from the China Health and Retirement Longitudinal Study. Logistic regression models were employed to examine the association between the CHG index and new-onset hypertension across different sex and glycemic statuses. Additionally, the net reclassification improvement and integrated discrimination improvement indices were calculated to estimate the additional predictive value beyond the basic model.
A total of 6555 participants were included in the study. A significant association between CHG index and new-onset hypertension was observed in the total, male, female, prediabetic, and diabetic populations, with adjusted OR (95% CI) of 1.16 (1.10-1.24), 1.23 (1.12-1.36), 1.12 (1.02-1.22), 1.14 (1.01-1.29), and 1.19 (1.03-1.36) respectively. Restricted Cubic Spline (RCS) analysis revealed a positive linear relationship between the CHG index and new-onset hypertension. The addition of either the CHG index or the Triglyceride-Glucose (TyG) index significantly improved the predictive performance of the basic model for hypertension.
An elevated CHG index is significantly associated with new-onset hypertension.
PMID:
42977683
Bibliographic data and abstract were imported from PubMed on 04 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0